Safety and feasibility of repeated intrathecal allogeneic bone marrow-derived mesenchymal stromal cells in patients with neurological diseases.

Authors
Category Systematic review
JournalStem Cells International
Year 2019
This article has no abstract
Epistemonikos ID: e8caba35b65cc5ffecf599909c06084ed045288b
First added on: Nov 29, 2019